Tuesday 25 August 2020

This page is meant to provide a look at the schedule and events that will occur during WC11 on Tuesday 25 August 2020.

* the program is subject to change


  • Disease (D)
  • Ethics, Welfare and regulation (E)
  • Innovative technologies (IT)
  • Safety (S)

07h30-18h00 Registration and poster display

08h30-09h30 Keynote Lecture
Novel non‐animal technologies in disease mechanisms  – Prof. dr. Donald Ingber, Wyss Institute for Biologically Inspired Engineering

09h30-11h00 Platform sessions

  • (D) S93: Reproducibility in preclinical studies – K. Reid, EFPIA
  • (E) S34: Systematic Review, Machine Learning and Data-Driven Alternatives – B. Lidbury, The Australian National University
  • (IT) S152: Organoid technology for infectious diseases: from innovation to established models – D. Pajkrt, Academic Medical Center
  • (S) S109: Computational Synthesis and Integration for Systems Toxicology in the Animal-free Zone – T. Knudsen, US EPA
  • (S) S164: Decision making in non-animal cosmetic safety assessment – P. Russell, Unilever
  • (D) S234: Reverse Translation: Maximizing clinical relevance while reducing the need for preclinical data – J. Aubrecht, Takeda
  • (S) S70: Challenges of Non-Animal Approaches for Food Safety & Nutrition in the 21st Century: From Inception to Application – L. Geurts, ILSI Europe
  • (E) Housing, care and animal training-TBD

11h00-11h30 Coffee break at the exhibition and poster area

11h30-13h00 Platform sessions

  • (D) S84: Beyond the 3Rs: Expanding the Use of Human-Relevant Replacement Methods in Biomedical Research – K. Herrmann, Johns Hopkins Bloomberg School of Public Health
  • (E) S143: Open Science and Transparency in Animal-Based Research – P. Jirkof, University Zurich / Laboratory Animals (Editor)
    *This session is sponsored and organized by Laboratory Animals Limited
  • (IT) S215: Emerging 3D organoid technology toward animal alternative testing – B. Anson, Stemonix
  • (S) S13: Flexible, efficient and performance-driven in-house method validation responding to current regulatory challenges for identifying human thyroid disruptors – S. Coecke, European Commission Joint Research Centre
  • (E) S200: Establishing a European Network of 3Rs Centers and 3Rs-Societies – H. Spielmann, EUSAAT (European Society for Alternatives to Animal Testing)
  • (S) S183: Alternative approaches and predictive methods to fish toxicity testing – V. Poulsen, L’Oréal
  • (S) S156: Human relevance in both dose and effect for in vitro testing of respiratory toxicity – Y. Staal, RIVM

13h00-14h30 Lunch break at the exhibition and poster area

YOU-WC11 – more information will follow soon

14h30-16h30 Platform sessions

  • (D) S105: The role of clinical research on the understanding and treatment of diseases – L. Bastos, Eurogroup for Animals
  • (E) S16: Focus on Severe Suffering – E. Lilley, RSPCA
  • (IT) S160: Human Organs-on-Chips: Advancing Regulatory Science through Innovation – S. Fitzpatrick, US Food and Drug Administration
  • (S) S60: New Approach Methods in AgroChemical Development and Regulatory Decisions – D. Wolf, Syngenta Crop Protection
    *This session is sponsored and organized by Syngenta
  • (E) S173: Culture of Care – a culture driven, pro-active approach towards improving standards – T. Bertelsen, Novo Nordisk
  • (IT) S199: Can non-animal models identify environmental endocrine disruptors? – N. Hallmark, Bayer AG
    *This session is sponsored and organized by Bayer AG
  • (D) S120: 3Rs in vaccines Development – D. Lambrigts, GSK

16h30-17h00 Coffee break at the exhibition and poster area

17h00-18h00 Keynote Lecture
Ethics of innovative technologies – Prof. dr. Annelien Bredenoord, UMC Utrecht